Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001

被引:82
作者
Lyytikäinen, O
Ruotsalainen, E
Järvinen, A
Valtonen, V
Ruutu, P
机构
[1] Natl Publ Hlth Inst, Dept Infect Dis Epidemiol, SF-00300 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki 00029, Finland
关键词
D O I
10.1007/s10096-005-1345-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In Finland, Staphylococcus aureus bloodstream infections are caused predominantly (> 99%) by methicillin-sensitive strains. In this study, laboratory-based surveillance data on Staphylococcus aureus bloodstream infections occurring in Finland from 1995 to 2001 were analyzed. Preceding hospitalizations for all persons with Staphylococcus aureus bloodstream infections were obtained from the national hospital discharge registry, and data on outcome was obtained from the national population registry. An infection was defined as nosocomial when a positive blood culture was obtained more than 2 days after hospital admission or within 2 days of admission if there was a preceding hospital discharge within 7 days. A total of 5,045 cases were identified. The annual incidence of Staphylococcus aureus bloodstream infection rose by 55%, from 11 per 100,000 population in 1995 to 17 in 2001. The increase was detected in all adult age groups, though it was most distinct in patients > 74 years of age. Nosocomial infections accounted for 51% of cases, a proportion that remained unchanged. The 28-day death-to-case ratio ranged from 1% in the age group 1-14 years to 33% in patients > 74 years of age. The 28-day death-to-case ratios for nosocomial and community-acquired infections were 22% and 13%, respectively, and did not change over time. The increase in incidence among elderly persons resulted in an increase in the annual rate of mortality associated with Staphylococcus aureus bloodstream infections, from 2.6 to 4.2 deaths per 100,000 population per year. Staphylococcus aureus bloodstream infections are increasing in Finland, a country with a very low prevalence of methicillin resistance. While the increase may be due in part to increased reporting, it also reflects a growing population at risk, affected by such factors as high age and/or severe comorbidity.
引用
收藏
页码:399 / 404
页数:6
相关论文
共 23 条
[1]  
[Anonymous], EARSS ANN REP 2001
[2]  
BANERJEE SN, 1991, AM J MED S3B, V91, P86
[3]   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[4]   Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America [J].
Diekema, DJ ;
Pfaller, MA ;
Jones, RN ;
Doern, GV ;
Kugler, KC ;
Beach, ML ;
Sader, HS .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (04) :257-271
[5]  
ESPERSEN F, 1994, J CHEMOTHERAPY, V6, P219
[6]   Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia [J].
Fätkenheuer, G ;
Preuss, M ;
Salzberger, B ;
Schmeisser, N ;
Cornely, OA ;
Wisplinghoff, H ;
Seifert, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (03) :157-162
[7]   Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998 [J].
Fluit, AC ;
Jones, ME ;
Schmitz, FJ ;
Acar, J ;
Gupta, R ;
Verhoef, J .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :454-460
[8]  
Frimodt-Moller Niels, 1997, Clin Microbiol Infect, V3, P297, DOI 10.1111/j.1469-0691.1997.tb00617.x
[9]  
GRIFFITHS C, 2004, HLTH STAT Q, V21, P15
[10]   Treatment and outcome of Staphylococcus aureus bacteremia -: A prospective study of 278 cases [J].
Jensen, AG ;
Wachmann, CH ;
Espersen, F ;
Scheibel, J ;
Skinhoj, P ;
Frimodt-Moller, N .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (01) :25-32